Resistance to 5-Fluorouracil
- 21 November 1998
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 31 (5) , 661-666
- https://doi.org/10.1016/s0306-3623(98)00191-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitroBiochemical Pharmacology, 1997
- Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβNature Medicine, 1997
- Thymidylate synthase: Structure, inhibition, and strained conformations during catalysisPharmacology & Therapeutics, 1997
- Nucleoside-Mediated Mitigation of 5-Fluorouracil-Induced Toxicity in Synchronized Murine Erythroleukemic CellsToxicology and Applied Pharmacology, 1997
- Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyCancer Letters, 1997
- An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drugBiochemical Pharmacology, 1997
- Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damageBritish Journal of Cancer, 1997
- Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapyBritish Journal of Cancer, 1997
- Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer CellsJapanese Journal of Cancer Research, 1996
- The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agentsInternational Journal of Cancer, 1995